PROM1 and cancer: CXCR4 has been shown to co-localize with CRC stem cell markers, such as Lgr5, CD133, and CD44, which are thought to be associated with the epithelial-mesenchymal transition process and resistance to cancer drug therapy [Figure 6][42].